To collect multicenter clinical studies of artificial intelligence (AI)-based multiparametric magnetic resonance imaging (mpMRI) in the diagnosis of prostate cancer and to analyze the diagnostic value of AI mpMRI for prostate cancer.
Methods:
PubMed
Chinese National Knowledge Infrastructure (CNKI)
Wanfang data
and China Biology Medicine disc (CBMdisc) were systematically searched. The mpMRI
prostate cancer
artificial intelligence
diagnosis
and multicenter studies were used as entry criteria to collect
relevant literature for review. The findings of the papers were analyzed in terms of study protocol design
patient population
AI-assisted methods
and diagnostic efficacy.
Results:
A total of 6 eligible papers were collected
and the first was published in 2018. In all 6 studies
the researchers invited multiple radiologists to interpretate the mpMRI images with the help of AI. Most studies concluded that there was an improvement in radiologists diagnostic efficacy with AI assistance. However
there was some variation in the study protocols reported in different literature
and some of the study designs were flawed.
Conclusion:
There are still few multicenter clinical studies of AI applied to prostate mpMRI
and the findings are inconsistent. Standardized clinical studies should be conducted in the future to further validate the value of AI in the diagnosis of mpMRI prostate cancer.